157 related articles for article (PubMed ID: 17066185)
21. Proteomics in South Africa: current status, challenges and prospects.
Ndimba BK; Thomas LA
Biotechnol J; 2008 Nov; 3(11):1368-74. PubMed ID: 19016510
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometry is only one piece of the puzzle in clinical proteomics.
McGuire JN; Overgaard J; Pociot F
Brief Funct Genomic Proteomic; 2008 Jan; 7(1):74-83. PubMed ID: 18308835
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics and proteomics approaches for aging research.
Raghothama C; Harsha HC; Prasad CK; Pandey A
Biogerontology; 2005; 6(4):227-32. PubMed ID: 16333756
[TBL] [Abstract][Full Text] [Related]
24. Recent developments in public proteomic MS repositories and pipelines.
Mead JA; Bianco L; Bessant C
Proteomics; 2009 Feb; 9(4):861-81. PubMed ID: 19212957
[TBL] [Abstract][Full Text] [Related]
25. CE at the omics level: towards systems biology--an update.
Song EJ; Babar SM; Oh E; Hasan MN; Hong HM; Yoo YS
Electrophoresis; 2008 Jan; 29(1):129-42. PubMed ID: 18040991
[TBL] [Abstract][Full Text] [Related]
26. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
27. Plasma-derived microparticles for biomarker discovery.
Smalley DM; Ley K
Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
[TBL] [Abstract][Full Text] [Related]
28. Interpretation of large-scale quantitative shotgun proteomic profiles for biomarker discovery.
Isserlin R; Emili A
Curr Opin Mol Ther; 2008 Jun; 10(3):231-42. PubMed ID: 18535930
[TBL] [Abstract][Full Text] [Related]
29. Proteomics analysis in lung cancer: challenges and opportunities.
Kikuchi T; Carbone DP
Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
[TBL] [Abstract][Full Text] [Related]
30. Practical proteomic biomarker discovery: taking a step back to leap forward.
Listgarten J; Emili A
Drug Discov Today; 2005 Dec; 10(23-24):1697-702. PubMed ID: 16376831
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
32. The role of electrophoresis in disease biomarker discovery.
Issaq HJ; Veenstra TD
Electrophoresis; 2007 Jun; 28(12):1980-8. PubMed ID: 17503404
[TBL] [Abstract][Full Text] [Related]
33. Genomics and proteomics in process development: opportunities and challenges.
Gupta P; Lee KH
Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
[TBL] [Abstract][Full Text] [Related]
34. Proteomic methods for biomarker discovery in urine.
Wilkey DW; Merchant ML
Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
[TBL] [Abstract][Full Text] [Related]
35. Representing, storing and accessing molecular interaction data: a review of models and tools.
Strömbäck L; Jakoniene V; Tan H; Lambrix P
Brief Bioinform; 2006 Dec; 7(4):331-8. PubMed ID: 17132622
[TBL] [Abstract][Full Text] [Related]
36. Application of a peptide-based PF2D platform for quantitative proteomics in disease biomarker discovery.
Lee HJ; Kang MJ; Lee EY; Cho SY; Kim H; Paik YK
Proteomics; 2008 Aug; 8(16):3371-81. PubMed ID: 18651672
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.
Csanky E; Olivova P; Rajnavolgyi E; Hempel W; Tardieu N; Katalin ET; Jullien A; Malderez-Bloes C; Kuras M; Duval MX; Nagy L; Scholtz B; Hancock W; Karger B; Guttman A; Takacs L
Electrophoresis; 2007 Dec; 28(23):4401-6. PubMed ID: 18041035
[TBL] [Abstract][Full Text] [Related]
38. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
39. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics.
Thongboonkerd V
Mol Biosyst; 2008 Aug; 4(8):810-5. PubMed ID: 18633482
[TBL] [Abstract][Full Text] [Related]
40. Guidelines for the next 10 years of proteomics.
Wilkins MR; Appel RD; Van Eyk JE; Chung MC; Görg A; Hecker M; Huber LA; Langen H; Link AJ; Paik YK; Patterson SD; Pennington SR; Rabilloud T; Simpson RJ; Weiss W; Dunn MJ
Proteomics; 2006 Jan; 6(1):4-8. PubMed ID: 16400714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
